Literature DB >> 27225638

Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript.

Mariana M Cajaiba1, Lawrence J Jennings1, David George1, Elizabeth J Perlman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27225638      PMCID： PMC4980203          DOI： 10.1002/gcc.22382

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN： 1045-2257            Impact factor:   5.006


× No keyword cloud information.
  12 in total

1.  RNF43 is frequently mutated in colorectal and endometrial cancers.

Authors:  Marios Giannakis; Eran Hodis; Xinmeng Jasmine Mu; Mai Yamauchi; Joseph Rosenbluh; Kristian Cibulskis; Gordon Saksena; Michael S Lawrence; Zhi Rong Qian; Reiko Nishihara; Eliezer M Van Allen; William C Hahn; Stacey B Gabriel; Eric S Lander; Gad Getz; Shuji Ogino; Charles S Fuchs; Levi A Garraway
Journal:  Nat Genet       Date:  2014-10-26       Impact factor: 38.330

2.  Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.

Authors:  Emiko Sugawara; Yuki Togashi; Naoto Kuroda; Seiji Sakata; Satoko Hatano; Reimi Asaka; Takeshi Yuasa; Junji Yonese; Masanobu Kitagawa; Hiroyuki Mano; Yuichi Ishikawa; Kengo Takeuchi
Journal:  Cancer       Date:  2012-01-17       Impact factor: 6.860

3.  Hook1, microtubules, and Rab22: mediators of selective sorting of clathrin-independent endocytic cargo proteins on endosomes.

Authors:  Lymarie Maldonado-Báez; Julie G Donaldson
Journal:  Bioarchitecture       Date:  2013-09-01

4.  ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients.

Authors:  William R Sukov; Jennelle C Hodge; Christine M Lohse; Monica K Akre; Bradley C Leibovich; R Houston Thompson; John C Cheville
Journal:  Mod Pathol       Date:  2012-06-29       Impact factor: 7.842

5.  ALK-rearranged renal cell carcinomas in children.

Authors:  Mariana M Cajaiba; Lawrence J Jennings; Stephen M Rohan; Antonio R Perez-Atayde; Adrian Marino-Enriquez; Jonathan A Fletcher; James I Geller; Katrin M C Leuer; Julia A Bridge; Elizabeth J Perlman
Journal:  Genes Chromosomes Cancer       Date:  2016-02-23       Impact factor: 5.006

6.  Elevation of Hook1 in a disease model of Batten disease does not affect a novel interaction between Ankyrin G and Hook1.

Authors:  Jill M Weimer; Subrata Chattopadhyay; Andrew W Custer; David A Pearce
Journal:  Biochem Biophys Res Commun       Date:  2005-05-20       Impact factor: 3.322

7.  Hook proteins: association with Alzheimer pathology and regulatory role of hook3 in amyloid beta generation.

Authors:  Lydia Herrmann; Caspar Wiegmann; Annika Arsalan-Werner; Isabel Hilbrich; Carsten Jäger; Katharina Flach; Anne Suttkus; Ingolf Lachmann; Thomas Arendt; Max Holzer
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

8.  ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients.

Authors:  Cheol Lee; Jeong Whan Park; Ja Hee Suh; Kyung Han Nam; Kyung Chul Moon
Journal:  Korean J Pathol       Date:  2013-10-25

9.  The landscape and therapeutic relevance of cancer-associated transcript fusions.

Authors:  K Yoshihara; Q Wang; W Torres-Garcia; S Zheng; R Vegesna; H Kim; R G W Verhaak
Journal:  Oncogene       Date:  2014-12-15       Impact factor: 9.867

10.  Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.

Authors:  Austin M Dulak; Petar Stojanov; Shouyong Peng; Michael S Lawrence; Cameron Fox; Chip Stewart; Santhoshi Bandla; Yu Imamura; Steven E Schumacher; Erica Shefler; Aaron McKenna; Scott L Carter; Kristian Cibulskis; Andrey Sivachenko; Gordon Saksena; Douglas Voet; Alex H Ramos; Daniel Auclair; Kristin Thompson; Carrie Sougnez; Robert C Onofrio; Candace Guiducci; Rameen Beroukhim; Zhongren Zhou; Lin Lin; Jules Lin; Rishindra Reddy; Andrew Chang; Rodney Landrenau; Arjun Pennathur; Shuji Ogino; James D Luketich; Todd R Golub; Stacey B Gabriel; Eric S Lander; David G Beer; Tony E Godfrey; Gad Getz; Adam J Bass
Journal:  Nat Genet       Date:  2013-03-24       Impact factor: 38.330
View more
  10 in total

1.  The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing.

Authors:  Mariana M Cajaiba; Lisa M Dyer; James I Geller; Lawrence J Jennings; David George; Dawn Kirschmann; Stephen M Rohan; Nicholas G Cost; Geetika Khanna; Elizabeth A Mullen; Jeffrey S Dome; Conrad V Fernandez; Elizabeth J Perlman
Journal:  Cancer       Date:  2018-06-15       Impact factor: 6.860

2.  Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Sean R Williamson; Anthony J Gill; Ondrej Hes; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-02-01       Impact factor: 7.842

Review 3.  Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many Faces.

Authors:  Hao Huang
Journal:  Int J Mol Sci       Date:  2018-11-02       Impact factor: 5.923

4.  Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.

Authors:  Liwei Jia; Maria I Carlo; Hina Khan; Gouri J Nanjangud; Satshil Rana; Robert Cimera; Yanming Zhang; A Ari Hakimi; Amit K Verma; Hikmat A Al-Ahmadie; Samson W Fine; Anuradha Gopalan; S Joseph Sirintrapun; Satish K Tickoo; Victor E Reuter; Benjamin A Gartrell; Ying-Bei Chen
Journal:  Mod Pathol       Date:  2019-04-12       Impact factor: 7.842

Review 5.  Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review.

Authors:  Giovanni Maria Iannantuono; Silvia Riondino; Stefano Sganga; Mario Roselli; Francesco Torino
Journal:  Int J Mol Sci       Date:  2022-04-03       Impact factor: 5.923

6.  Pediatric onco-nephrology: time to spread the word : Part I: early kidney involvement in children with malignancy.

Authors:  Arwa Nada; Jennifer G Jetton
Journal:  Pediatr Nephrol       Date:  2020-11-27       Impact factor: 3.714

7.  ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217.

Authors:  Naoto Kuroda; Kiril Trpkov; Yuan Gao; Maria Tretiakova; Yajuan J Liu; Monika Ulamec; Kengo Takeuchi; Abbas Agaimy; Christopher Przybycin; Cristina Magi-Galluzzi; Soichiro Fushimi; Fumiyoshi Kojima; Malthide Sibony; Jen-Fan Hang; Chin-Chen Pan; Asli Yilmaz; Farshid Siadat; Emiko Sugawara; Pierre-Alexandre Just; Nikola Ptakova; Ondrej Hes
Journal:  Mod Pathol       Date:  2020-05-28       Impact factor: 7.842

Review 8.  Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.

Authors:  Kentaro Inamura
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

Review 9.  ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review.

Authors:  Jing Yang; Lei Dong; Hong Du; Xiu-Bo Li; Yan-Xiao Liang; Guo-Rong Liu
Journal:  Diagn Pathol       Date:  2019-10-18       Impact factor: 2.644

Review 10.  Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach.

Authors:  Reza Alaghehbandan; Delia Perez Montiel; Ana Silvia Luis; Ondrej Hes
Journal:  Cancers (Basel)       Date:  2019-12-30       Impact factor: 6.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.